Catalyst Wire Dossier Catalyst Wire Dossier

RET inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RET inhibitor, covering 2024-08-02 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

See pricing